162 related articles for article (PubMed ID: 9409631)
1. A single amino acid substitution (Leu160His) in cytochrome P450 CYP2A6 causes switching from 7-hydroxylation to 3-hydroxylation of coumarin.
Hadidi H; Zahlsen K; Idle JR; Cholerton S
Food Chem Toxicol; 1997 Sep; 35(9):903-7. PubMed ID: 9409631
[TBL] [Abstract][Full Text] [Related]
2. Determination of coumarin metabolism in Turkish population.
Cok I; Aygün Kocabaş N; Cholerton S; Karakaya AE; Sardaş S
Hum Exp Toxicol; 2001 Apr; 20(4):179-84. PubMed ID: 11393269
[TBL] [Abstract][Full Text] [Related]
3. Variability of coumarin 7- and 3-hydroxylation in a Jordanian population is suggestive of a functional polymorphism in cytochrome P450 CYP2A6.
Hadidi H; Irshaid Y; Vågbø CB; Brunsvik A; Cholerton S; Zahlsen K; Idle JR
Eur J Clin Pharmacol; 1998 Jul; 54(5):437-41. PubMed ID: 9754990
[TBL] [Abstract][Full Text] [Related]
4. Interindividual variability of coumarin 7-hydroxylation in healthy volunteers.
Rautio A; Kraul H; Kojo A; Salmela E; Pelkonen O
Pharmacogenetics; 1992 Oct; 2(5):227-33. PubMed ID: 1306122
[TBL] [Abstract][Full Text] [Related]
5. Variation in coumarin 7-hydroxylase activity associated with genetic polymorphism of cytochrome P450 2A6 and the body status of iron stores in adult Thai males and females.
Ujjin P; Satarug S; Vanavanitkun Y; Daigo S; Ariyoshi N; Yamazaki H; Reilly PE; Moore MR; Kamataki T
Pharmacogenetics; 2002 Apr; 12(3):241-9. PubMed ID: 11927840
[TBL] [Abstract][Full Text] [Related]
6. A new deleted allele in the human cytochrome P450 2A6 (CYP2A6) gene found in individuals showing poor metabolic capacity to coumarin and (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride (SM-12502).
Nunoya K; Yokoi T; Kimura K; Inoue K; Kodama T; Funayama M; Nagashima K; Funae Y; Green C; Kinoshita M; Kamataki T
Pharmacogenetics; 1998 Jun; 8(3):239-49. PubMed ID: 9682269
[TBL] [Abstract][Full Text] [Related]
7. Coumarin metabolism by rat esophageal microsomes and cytochrome P450 2A3.
von Weymarn LB; Murphy SE
Chem Res Toxicol; 2001 Oct; 14(10):1386-92. PubMed ID: 11599930
[TBL] [Abstract][Full Text] [Related]
8. CYP2A6: a human coumarin 7-hydroxylase.
Pelkonen O; Rautio A; Raunio H; Pasanen M
Toxicology; 2000 Apr; 144(1-3):139-47. PubMed ID: 10781881
[TBL] [Abstract][Full Text] [Related]
9. CYP2A6 genetic polymorphisms and liver microsomal coumarin and nicotine oxidation activities in Japanese and Caucasians.
Inoue K; Yamazaki H; Shimada T
Arch Toxicol; 2000 Jan; 73(10-11):532-9. PubMed ID: 10663384
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of coumarin 7-hydroxylase activity in human liver microsomes.
Draper AJ; Madan A; Parkinson A
Arch Biochem Biophys; 1997 May; 341(1):47-61. PubMed ID: 9143352
[TBL] [Abstract][Full Text] [Related]
11. Species differences and interindividual variation in liver microsomal cytochrome P450 2A enzymes: effects on coumarin, dicumarol, and testosterone oxidation.
Pearce R; Greenway D; Parkinson A
Arch Biochem Biophys; 1992 Oct; 298(1):211-25. PubMed ID: 1381906
[TBL] [Abstract][Full Text] [Related]
12. Single-dose disulfiram does not inhibit CYP2A6 activity.
Kharasch ED; Hankins DC; Baxter PJ; Thummel KE
Clin Pharmacol Ther; 1998 Jul; 64(1):39-45. PubMed ID: 9695717
[TBL] [Abstract][Full Text] [Related]
13. CYP2A13-catalysed coumarin metabolism: comparison with CYP2A5 and CYP2A6.
von Weymarn LB; Murphy SE
Xenobiotica; 2003 Jan; 33(1):73-81. PubMed ID: 12519695
[TBL] [Abstract][Full Text] [Related]
14. Ethnic-related differences in coumarin 7-hydroxylation activities catalyzed by cytochrome P4502A6 in liver microsomes of Japanese and Caucasian populations.
Shimada T; Yamazaki H; Guengerich FP
Xenobiotica; 1996 Apr; 26(4):395-403. PubMed ID: 9173680
[TBL] [Abstract][Full Text] [Related]
15. Spectrofluorometric analysis of CYP2A6-catalyzed coumarin 7-hydroxylation.
Waxman DJ; Chang TK
Methods Mol Biol; 1998; 107():111-6. PubMed ID: 14577218
[No Abstract] [Full Text] [Related]
16. Identification of Val117 and Arg372 as critical amino acid residues for the activity difference between human CYP2A6 and CYP2A13 in coumarin 7-hydroxylation.
He XY; Shen J; Hu WY; Ding X; Lu AY; Hong JY
Arch Biochem Biophys; 2004 Jul; 427(2):143-53. PubMed ID: 15196988
[TBL] [Abstract][Full Text] [Related]
17. In vivo evaluation of coumarin and nicotine as probe drugs to predict the metabolic capacity of CYP2A6 due to genetic polymorphism in Thais.
Peamkrasatam S; Sriwatanakul K; Kiyotani K; Fujieda M; Yamazaki H; Kamataki T; Yoovathaworn K
Drug Metab Pharmacokinet; 2006 Dec; 21(6):475-84. PubMed ID: 17220563
[TBL] [Abstract][Full Text] [Related]
18. Effect of cigarette smoking on coumarin metabolism in humans.
Poland RE; Pechnick RN; Cloak CC; Wan YJ; Nuccio I; Lin KM
Nicotine Tob Res; 2000 Nov; 2(4):351-4. PubMed ID: 11197315
[TBL] [Abstract][Full Text] [Related]
19. Species differences in coumarin metabolism: a molecular modelling evaluation of CYP2A interactions.
Lewis DF; Lake BG
Xenobiotica; 2002 Jul; 32(7):547-61. PubMed ID: 12162851
[TBL] [Abstract][Full Text] [Related]
20. A novel single nucleotide polymorphism altering stability and activity of CYP2a6.
Ariyoshi N; Sawamura Y; Kamataki T
Biochem Biophys Res Commun; 2001 Mar; 281(3):810-4. PubMed ID: 11237731
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]